Press Release: Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology

"Clinicians are overloaded with sometimes distracting materials, so they still very much need the right, evidence-based information at the right time in order to choose the most appropriate treatment for each patient," said Robert Dunlop, Clinical Director at InferMed. "Arezzo only offers information that's pertinent to the case in hand, yet the complete guideline remains in the background should complex cases demand little-used pathways.

"Together, with the global reach of Elsevier, we can further address the needs of acute and primary care institutions. We have a greater opportunity to meet that need as a part of Elsevier Clinical Solutions," Dunlop said.

InferMed is headquartered in London and has employees in France, Australia and New Zealand. The acquisition is effective immediately and financial terms of the transaction are not being disclosed.

About InferMed
Launched in 1999 as a joint venture with the UK's largest cancer charity, CRUK, InferMed has become a leader in providing software and services to the healthcare, pharmaceutical, and clinical research sectors with whom it works in close collaboration. InferMed offers innovative software solutions for collecting and managing data. Through both its MACRO EDC application and Arezzo® decision support technology, InferMed's products are designed to improve patient outcomes and help healthcare providers to practise more efficiently.

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey- and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries. www.elsevier.com